Cefazolin: Difference between revisions
| Line 21: | Line 21: | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
===General (<7 Days)=== | |||
*40 mg/kg/day IM/IV divided q12h | |||
*First Dose: 20mg/kg IM/IV x 1 | |||
*Max 6g/day | |||
===General (>7 Days - 1 Month)=== | |||
*<2000g | |||
**40 mg/kg/day IM/IV divided q12h | |||
**First Dose: 20mg/kg IM/IV x 1 | |||
**Max 6g/day | |||
*>2000g | |||
**60 mg/kg/day IM/IV divided q8h | |||
**First Dose: 20mg/kg IM/IV x 1 | |||
**Max 6g/day | |||
===General (>1 Month)=== | |||
*25-100 mg/kg/day IM/IV divided q6-8h | |||
*First Dose: 20-33mg/kg IM/IV x 1 | |||
*Max 6g/day | |||
===Community Acquired [[Pneumonia]] (>3 Months)=== | |||
*150 mg/kg/day IM/IV divided q8h x 10 days | |||
*First Dose: 50 mg/kg IM/IV x 1 | |||
*May switch to PO regimen when able | |||
==Special Populations== | ==Special Populations== | ||
Revision as of 22:36, 27 February 2014
General
- Type: 1st gen Cephalosporin
- Dosage Forms: IV, IM
- Common Trade Names: Ancef
Adult Dosing
General
- Mild: 250-500 mg IM/IV 8h
- Mod-Severe: 500-1000 mg IM/IV q6-8h
- Life Threatening: 1-1.5g IM/IV q6h
- Max: 12g/day
UTI, Uncomplicated
- 1g IM/IV q12
Pneumococcal Pneumonia
- 500mg IM/IV q12
Endocarditis Prophylaxis, Dental
- 1g IM/IV x1 (30-60 min before procedure)
Pediatric Dosing
General (<7 Days)
- 40 mg/kg/day IM/IV divided q12h
- First Dose: 20mg/kg IM/IV x 1
- Max 6g/day
General (>7 Days - 1 Month)
- <2000g
- 40 mg/kg/day IM/IV divided q12h
- First Dose: 20mg/kg IM/IV x 1
- Max 6g/day
- >2000g
- 60 mg/kg/day IM/IV divided q8h
- First Dose: 20mg/kg IM/IV x 1
- Max 6g/day
General (>1 Month)
- 25-100 mg/kg/day IM/IV divided q6-8h
- First Dose: 20-33mg/kg IM/IV x 1
- Max 6g/day
Community Acquired Pneumonia (>3 Months)
- 150 mg/kg/day IM/IV divided q8h x 10 days
- First Dose: 50 mg/kg IM/IV x 1
- May switch to PO regimen when able
Special Populations
- Pregnancy: B
- Lactation: Safe
- Renal
- Hepatic
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life: 1.8h (3.7 ESRD)
- Metabolism: other; CYP450
- Excretion: Urine
- Mechanism of Action: Bactericidal; inhibits cell wall mucopeptide synthesis
See Also
Source
- Epocrates
